UNDERWRITING AGREEMENT betweenUnderwriting Agreement • June 15th, 2020 • BioCardia, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledJune 15th, 2020 Company Industry JurisdictionAs Representative of the several Underwriters named on Schedule 1 attached hereto 590 Madison Avenue, 36th Floor New York, New York 10022
PRE-FUNDED COMMON STOCK PURCHASE WARRANT biocardia, INC.Pre-Funded Common Stock Purchase Warrant • June 15th, 2020 • BioCardia, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledJune 15th, 2020 Company Industry JurisdictionTHIS PRE-FUNDED COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) until this Warrant is exercised in full (the “Termination Date”) but not thereafter, to subscribe for and purchase from BioCardia, Inc., Inc., a Delaware corporation (the “Company”), up to ______ shares of common stock, par value $0.001 per share (the “Common Stock”) (as subject to adjustment hereunder, the “Warrant Shares”). The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).